KNSA vs. CAT

Last updated Jun 4, 2026

KNSA (Kiniksa Pharmaceuticals, Ltd.) and CAT (Caterpillar Inc.) are both stocks. KNSA operates in Biotechnology (Healthcare), while CAT operates in Farm & Heavy Construction Machinery (Industrials). Over the past 5 years, KNSA returned 29.11%/yr vs 32.93%/yr for CAT. At a 0.17 correlation, their price movements are largely independent.

Performance

KNSA vs. CAT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Kiniksa Pharmaceuticals, Ltd. (KNSA) and Caterpillar Inc. (CAT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, KNSA achieves a 16.00% return, which is significantly lower than CAT's 62.36% return.

KNSA

• 1D: 1.98%
• 1M: -16.96%
• YTD: 16.00%
• 6M: 17.89%
• 1Y: 64.38%
• 3Y*: 48.51%
• 5Y*: 29.11%
• 10Y*: —

CAT

• 1D: 1.80%
• 1M: 5.88%
• YTD: 62.36%
• 6M: 57.25%
• 1Y: 167.95%
• 3Y*: 62.31%
• 5Y*: 32.93%
• 10Y*: 31.52%

*Multi-year figures are annualized to reflect compound growth (CAGR)

KNSA vs. CAT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
KNSA Kiniksa Pharmaceuticals, Ltd.	16.00%	108.54%	12.77%	17.09%	27.27%	-33.39%	59.76%	-60.63%	44.27%
CAT Caterpillar Inc.	62.36%	60.30%	24.66%	25.95%	18.60%	15.95%	26.97%	19.51%	-18.41%

Correlation

The correlation between KNSA and CAT is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.14
Correlation (3Y) Calculated over the trailing 3-year period	0.22
Correlation (5Y) Calculated over the trailing 5-year period	0.18
Correlation (All Time) Calculated using the full available price history since May 25, 2018	0.17

Fundamentals

Market Cap KNSA : $3.94B CAT : $431.41B
EPS KNSA : $0.92 CAT : $20.07
PE Ratio KNSA : 51.96 CAT : 46.14
PEG Ratio KNSA : 0.50 CAT : 3.05
PS Ratio KNSA : 5.03 CAT : 6.14
PB Ratio KNSA : 6.51 CAT : 23.12
Total Revenue (TTM) KNSA : $754.05M CAT : $70.76B
Gross Profit (TTM) KNSA : $294.06M CAT : $23.01B
EBITDA (TTM) KNSA : $101.06M CAT : $15.31B

Return for Risk

KNSA vs. CAT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

KNSA

KNSA Risk / Return Rank: 83
KNSA Sharpe Ratio Rank: 81
KNSA Sortino Ratio Rank: 81
KNSA Omega Ratio Rank: 79
KNSA Calmar Ratio Rank: 83
KNSA Martin Ratio Rank: 89

CAT

CAT Risk / Return Rank: 98
CAT Sharpe Ratio Rank: 98
CAT Sortino Ratio Rank: 98
CAT Omega Ratio Rank: 97
CAT Calmar Ratio Rank: 98
CAT Martin Ratio Rank: 99

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

KNSA vs. CAT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Kiniksa Pharmaceuticals, Ltd. (KNSA) and Caterpillar Inc. (CAT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	KNSA	CAT	Difference
Sharpe ratio Return per unit of total volatility	1.48	4.98	-3.49
Sortino ratio Return per unit of downside risk	2.38	5.68	-3.29
Omega ratio Gain probability vs. loss probability	1.30	1.72	-0.42
Calmar ratio Return relative to maximum drawdown	3.06	12.18	-9.11
Martin ratio Return relative to average drawdown	11.39	40.49	-29.10
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

KNSA vs. CAT - Sharpe Ratio Comparison

The current KNSA Sharpe Ratio is 1.48, which is lower than the CAT Sharpe Ratio of 4.98. The chart below compares the historical Sharpe Ratios of KNSA and CAT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	KNSA	CAT	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.48	4.98	-3.49
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.55	1.08	-0.53
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	1.02	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.19	0.35	-0.17

Drawdowns

KNSA vs. CAT - Drawdown Comparison

The maximum KNSA drawdown since its inception was -83.06%, which is greater than CAT's maximum drawdown of -73.43%. Use the drawdown chart below to compare losses from any high point for KNSA and CAT.

Drawdown Indicators

	KNSA	CAT	Difference
Max Drawdown Largest peak-to-trough decline	-83.06%	-73.43%	-9.63%
Max Drawdown (1Y) Largest decline over 1 year	-21.12%	-13.88%	-7.24%
Max Drawdown (3Y) Largest decline over 3 years	-34.14%	-34.05%	-0.09%
Max Drawdown (5Y) Largest decline over 5 years	-53.17%	-34.05%	-19.12%
Max Drawdown (10Y) Largest decline over 10 years	—	-43.36%	—
Current Drawdown Current decline from peak	-19.55%	-0.08%	-19.47%
Average Drawdown Average peak-to-trough decline	-40.26%	-19.74%	-20.52%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.67%	4.17%	+1.50%

Volatility

KNSA vs. CAT - Volatility Comparison

The current volatility for Kiniksa Pharmaceuticals, Ltd. (KNSA) is 10.38%, while Caterpillar Inc. (CAT) has a volatility of 11.17%. This indicates that KNSA experiences smaller price fluctuations and is considered to be less risky than CAT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	KNSA	CAT	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.38%	11.17%	-0.79%
Volatility (6M) Calculated over the trailing 6-month period	33.56%	27.09%	+6.47%
Volatility (1Y) Calculated over the trailing 1-year period	43.77%	33.97%	+9.80%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	53.49%	30.62%	+22.87%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	63.66%	30.86%	+32.80%

Dividends

KNSA vs. CAT - Dividend Comparison

KNSA has not paid dividends to shareholders, while CAT's dividend yield for the trailing twelve months is around 0.65%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CAT Caterpillar Inc.	0.65%	1.02%	1.49%	1.69%	1.93%	2.07%	2.26%	2.56%	2.58%	1.97%	3.32%	4.33%
KNSA Kiniksa Pharmaceuticals, Ltd.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

KNSA vs. CAT - Profitability Comparison

The chart below illustrates the profitability comparison between Kiniksa Pharmaceuticals, Ltd. and Caterpillar Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

KNSA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Kiniksa Pharmaceuticals, Ltd. reported a gross profit of 0.00 and revenue of 214.27M. Therefore, the gross margin over that period was 0.0%.

CAT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Caterpillar Inc. reported a gross profit of 6.11B and revenue of 17.42B. Therefore, the gross margin over that period was 35.1%.

KNSA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Kiniksa Pharmaceuticals, Ltd. reported an operating income of 29.27M and revenue of 214.27M, resulting in an operating margin of 13.7%.

CAT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Caterpillar Inc. reported an operating income of 3.09B and revenue of 17.42B, resulting in an operating margin of 17.7%.

KNSA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Kiniksa Pharmaceuticals, Ltd. reported a net income of 22.59M and revenue of 214.27M, resulting in a net margin of 10.5%.

CAT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Caterpillar Inc. reported a net income of 2.55B and revenue of 17.42B, resulting in a net margin of 14.6%.

Frequently Asked Questions

Can I hold both KNSA and CAT in my portfolio?

KNSA and CAT have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, KNSA or CAT?

CAT has higher volatility (11.17%) compared to KNSA (10.38%). In terms of maximum drawdown, KNSA dropped -83.06% vs CAT's -73.43%.

Which has better risk-adjusted returns?

CAT currently has the higher Sharpe Ratio (4.98 vs 1.48), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.